Relief Therapeutics Holding AG Appoints Drew Cronin-Fine as Executive Director, Head of U.S. Marketing

Relief Therapeutics Holding AG announced the appointment, effective May 3, 2022, of Drew Cronin-Fine as Executive Director, Head of U.S. Marketing. In this newly created position, Ms. Cronin-Fine will be responsible for building and leading the U.S. Marketing team. She will report to Anthony Kim, Senior Vice President and Head of U.S. Commercial Operations.

Prior to joining Relief, for the past seven years, Ms. Cronin-Fine held numerous positions of increasing responsibility in U.S. Marketing at Intercept Pharmaceuticals Inc.